Hartford Financial Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7K | Hold |
353
| – | – | ﹤0.01% | 274 |
|
|
2025
Q1 | $13.9K | Hold |
353
| – | – | ﹤0.01% | 276 |
|
|
2024
Q4 | $10.6K | Hold |
353
| – | – | ﹤0.01% | 296 |
|
|
2024
Q3 | $8.26K | Hold |
353
| – | – | ﹤0.01% | 309 |
|
|
2024
Q2 | $6.28K | Hold |
353
| – | – | ﹤0.01% | 319 |
|
|
2024
Q1 | $5.37K | Hold |
353
| – | – | ﹤0.01% | 329 |
|
|
2023
Q4 | $6.03K | Hold |
353
| – | – | ﹤0.01% | 330 |
|
|
2023
Q3 | $2.95K | Hold |
353
| – | – | ﹤0.01% | 353 |
|
|
2023
Q2 | $8.77K | Hold |
353
| – | – | ﹤0.01% | 293 |
|
|
2023
Q1 | $5.31K | Hold |
353
| – | – | ﹤0.01% | 309 |
|
|
2022
Q4 | $4.18K | Hold |
353
| – | – | ﹤0.01% | 313 |
|
|
2022
Q3 | $2K | Hold |
353
| – | – | ﹤0.01% | 359 |
|
|
2022
Q2 | $2K | Hold |
353
| – | – | ﹤0.01% | 365 |
|
|
2022
Q1 | $3K | Hold |
353
| – | – | ﹤0.01% | 359 |
|
|
2021
Q4 | $7K | Hold |
353
| – | – | ﹤0.01% | 309 |
|
|
2021
Q3 | $12K | Hold |
353
| – | – | ﹤0.01% | 281 |
|
|
2021
Q2 | $14K | Hold |
353
| – | – | ﹤0.01% | 276 |
|
|
2021
Q1 | $17K | Buy |
353
+158
| +81% | +$7.61K | ﹤0.01% | 263 |
|
|
2020
Q4 | $10K | Hold |
195
| – | – | ﹤0.01% | 285 |
|
|
2020
Q3 | $5K | Hold |
195
| – | – | ﹤0.01% | 292 |
|
|
2020
Q2 | $4K | Hold |
195
| – | – | ﹤0.01% | 307 |
|
|
2020
Q1 | $2K | Buy |
+195
| New | +$2K | ﹤0.01% | 331 |
|